Adipocyte triglyceride accumulation

Adipocyte triglyceride accumulation is the physiological process by which adipocytes store energy in the form of neutral lipids within specialized organelles known as lipid droplets. This process is fundamental to energy homeostasis, allowing the body to sequester excess calories for later use during periods of energy deficit (PMID: 28432287). It is regulated by a complex network of enzymes, including Diacylglycerol O-acyltransferase (DGAT), and transcription factors like Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (PMID: 22503007). Pathological expansion of triglyceride stores leads to obesity and is strongly associated with the development of insulin resistance, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD) (PMID: 31064798). Therapeutic strategies often focus on modulating the rate of synthesis or breakdown of these lipid stores to mitigate metabolic dysfunction. Drugs such as thiazolidinediones act by promoting healthy adipocyte differentiation and lipid storage to prevent ectopic fat deposition, while lipase inhibitors reduce the absorption of fats that contribute to these stores. Monitoring this process through biomarkers like serum triglycerides and adiponectin is crucial for managing metabolic syndrome and its associated cardiovascular risks.

Other names

Lipid droplet formationAdipocyte lipogenesisFat storageTriglyceride synthesis in adipocytesAdipocyte hypertrophy

Modulation of adipogenesis via PPAR-gamma activation, inhibition of gastric and pancreatic lipases to reduce fatty acid availability, or direct inhibition of enzymes like DGAT1/2 that catalyze the final step of triglyceride synthesis.